Showing results (431-440 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|August 22, 2018
Inhibition of Herpes Simplex Virus-1 Entry into Human Cells by Nonsaccharide Glycosaminoglycan MimeticsRahaman Navaz Gangji, Nehru Viji Sankaranarayanan, James Elste, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Lead Optimization of 5-Aryl Benzimidazolone- and Oxindole-Based AMPA Receptor Modulators Selective for TARP γ-8Suchitra Ravula, Brad M Savall, Nyantsz Wu, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Nicotinamide Phosphoribosyltransferase Inhibitor as a Novel Payload for Antibody-Drug ConjugatesAlexei S Karpov, Tinya Abrams, Suzanna Clark, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP-TEAD Protein-Protein InteractionZhisen Zhang, Zhaohu Lin, Zheng Zhou, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Multiple fragment docking and linking in primary and secondary pockets of dopamine receptorsMárton Vass, Eva Agai-Csongor, Ferenc Horti, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Potent, long-acting cyclopentane-1,3-Dione thromboxane (A2)-receptor antagonistsXiaozhao Wang, Li Liu, Longchuan Huang, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Structure-Based Design of a Potent, Selective, and Brain Penetrating PDE2 Inhibitor with Demonstrated Target EngagementPeter Buijnsters, Meri De Angelis, Xavier Langlois, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Fragment-based discovery of type I inhibitors of maternal embryonic leucine zipper kinaseChristopher N Johnson, Valerio Berdini, Lijs Beke, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR InhibitorsPaul A Barsanti, Robert J Aversa, Xianming Jin, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Structure-Based Drug Design of Novel, Potent, and Selective Azabenzimidazoles (ABI) as ATR InhibitorsPaul A Barsanti, Yue Pan, Yipin Lu, et al.
Pageof 438